Listed

Alto Neuroscience, Inc.

ANRONYSECIK 1999480HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$29.1m, Q2 FY2026
Net income−$27.6m, Q2 FY2026
Alto Neuroscience, Inc., income statement, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m8.0Research and development, period not labelled, three months to 2023-09-30$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure9.6Research and development, period not labelled, three months to 2023-12-31$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0001999480-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure10.0Research and development, Q1 FY2024, three months to 2024-03-31$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure13.2Research and development, Q2 FY2024, three months to 2024-06-30$13.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure13.1Research and development, Q3 FY2024, three months to 2024-09-30$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure10.8Research and development, Q4 FY2024, three months to 2024-12-31$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure10.0Research and development, Q1 FY2025, three months to 2025-03-31$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure13.1Research and development, Q2 FY2025, three months to 2025-06-30$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure10.5Research and development, Q3 FY2025, three months to 2025-09-30$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure12.0Research and development, Q4 FY2025, three months to 2025-12-31$12.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure20.3Research and development, Q1 FY2026, three months to 2026-03-31$20.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure22.1Research and development, Q2 FY2026, three months to 2026-06-30$22.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Operating income$m(9.7)Operating income, period not labelled, three months to 2023-09-30−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure(11.8)Operating income, period not labelled, three months to 2023-12-31−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001999480-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating income, Q1 FY2024, three months to 2024-03-31−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure(18.3)Operating income, Q2 FY2024, three months to 2024-06-30−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure(18.9)Operating income, Q3 FY2024, three months to 2024-09-30−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure(17.0)Operating income, Q4 FY2024, three months to 2024-12-31−$17.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure(15.7)Operating income, Q1 FY2025, three months to 2025-03-31−$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure(18.7)Operating income, Q2 FY2025, three months to 2025-06-30−$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure(15.0)Operating income, Q3 FY2025, three months to 2025-09-30−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure(17.1)Operating income, Q4 FY2025, three months to 2025-12-31−$17.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure(27.1)Operating income, Q1 FY2026, three months to 2026-03-31−$27.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure(29.1)Operating income, Q2 FY2026, three months to 2026-06-30−$29.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Interest expense$m0.4Interest expense, period not labelled, three months to 2023-09-30$363.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure0.4Interest expense, period not labelled, three months to 2023-12-31$356.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-20, accession 0001999480-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2024, three months to 2024-03-31$346.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure0.3Interest expense, Q2 FY2024, three months to 2024-06-30$347.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure0.3Interest expense, Q3 FY2024, three months to 2024-09-30$349.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure0.3Interest expense, Q4 FY2024, three months to 2024-12-31$333.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2025, three months to 2025-03-31$598.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure0.6Interest expense, Q2 FY2025, three months to 2025-06-30$646.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure0.7Interest expense, Q3 FY2025, three months to 2025-09-30$650.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure0.6Interest expense, Q4 FY2025, three months to 2025-12-31$575.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure0.5Interest expense, Q1 FY2026, three months to 2026-03-31$545.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure0.5Interest expense, Q2 FY2026, three months to 2026-06-30$491.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Income tax$mnot reportednot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-13, accession 0001999480-24-000035. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001999480-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001999480-25-000076. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001999480-25-000090. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$m(9.1)Net income, period not labelled, three months to 2023-09-30−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure(11.2)Net income, period not labelled, three months to 2023-12-31−$11.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001999480-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(13.4)Net income, Q1 FY2024, three months to 2024-03-31−$13.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure(16.0)Net income, Q2 FY2024, three months to 2024-06-30−$16.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure(16.8)Net income, Q3 FY2024, three months to 2024-09-30−$16.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure(15.2)Net income, Q4 FY2024, three months to 2024-12-31−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure(15.2)Net income, Q1 FY2025, three months to 2025-03-31−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure(17.7)Net income, Q2 FY2025, three months to 2025-06-30−$17.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure(14.2)Net income, Q3 FY2025, three months to 2025-09-30−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure(16.2)Net income, Q4 FY2025, three months to 2025-12-31−$16.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure(26.2)Net income, Q1 FY2026, three months to 2026-03-31−$26.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure(27.6)Net income, Q2 FY2026, three months to 2026-06-30−$27.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Diluted EPS$ per share(2.44)Diluted EPS, period not labelled, three months to 2023-09-30−$2.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figurenot reported(0.76)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure(0.60)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure(0.62)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figurenot reported(0.56)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure(0.65)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure(0.52)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figurenot reported(0.80)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure(0.65)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Basic EPS$ per share(2.44)Basic EPS, period not labelled, three months to 2023-09-30−$2.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figurenot reported(0.76)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure(0.60)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure(0.62)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figurenot reported(0.56)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure(0.65)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure(0.52)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figurenot reported(0.80)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure(0.65)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure

Balance sheet

Cash and equivalents$243.7m, Q2 FY2026
Long-term debt$12.4m, Q2 FY2026
Shareholders' equity$219.2m, Q2 FY2026
Alto Neuroscience, Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported82.5Cash and equivalents, period not labelled, at 2023-12-31$82.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001999480-25-000025.Report this figure206Cash and equivalents, Q1 FY2024, at 2024-03-31$205.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure193Cash and equivalents, Q2 FY2024, at 2024-06-30$193.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001999480-24-000035.Report this figure182Cash and equivalents, Q3 FY2024, at 2024-09-30$181.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure168Cash and equivalents, FY2024, at 2024-12-31$168.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001999480-26-000002.Report this figure161Cash and equivalents, Q1 FY2025, at 2025-03-31$160.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure148Cash and equivalents, Q2 FY2025, at 2025-06-30$147.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure138Cash and equivalents, Q3 FY2025, at 2025-09-30$137.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure176Cash and equivalents, FY2025, at 2025-12-31$176.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure264Cash and equivalents, Q1 FY2026, at 2026-03-31$263.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure244Cash and equivalents, Q2 FY2026, at 2026-06-30$243.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Current assets$mnot reported85.4Current assets, period not labelled, at 2023-12-31$85.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001999480-25-000025.Report this figure208Current assets, Q1 FY2024, at 2024-03-31$208.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure195Current assets, Q2 FY2024, at 2024-06-30$195.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001999480-24-000035.Report this figure184Current assets, Q3 FY2024, at 2024-09-30$183.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure169Current assets, FY2024, at 2024-12-31$169.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001999480-26-000002.Report this figure164Current assets, Q1 FY2025, at 2025-03-31$163.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure150Current assets, Q2 FY2025, at 2025-06-30$149.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure139Current assets, Q3 FY2025, at 2025-09-30$139.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure178Current assets, FY2025, at 2025-12-31$177.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure269Current assets, Q1 FY2026, at 2026-03-31$269.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure247Current assets, Q2 FY2026, at 2026-06-30$247.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Total assets$mnot reported86.6Total assets, period not labelled, at 2023-12-31$86.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001999480-25-000025.Report this figure210Total assets, Q1 FY2024, at 2024-03-31$209.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure197Total assets, Q2 FY2024, at 2024-06-30$197.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001999480-24-000035.Report this figure192Total assets, Q3 FY2024, at 2024-09-30$191.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure178Total assets, FY2024, at 2024-12-31$177.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001999480-26-000002.Report this figure172Total assets, Q1 FY2025, at 2025-03-31$171.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure158Total assets, Q2 FY2025, at 2025-06-30$157.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure147Total assets, Q3 FY2025, at 2025-09-30$147.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure185Total assets, FY2025, at 2025-12-31$184.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure276Total assets, Q1 FY2026, at 2026-03-31$276.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure254Total assets, Q2 FY2026, at 2026-06-30$254.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Current liabilities$mnot reported5.6Current liabilities, period not labelled, at 2023-12-31$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001999480-25-000025.Report this figure8.0Current liabilities, Q1 FY2024, at 2024-03-31$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure9.8Current liabilities, Q2 FY2024, at 2024-06-30$9.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001999480-24-000035.Report this figure14.0Current liabilities, Q3 FY2024, at 2024-09-30$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure10.0Current liabilities, FY2024, at 2024-12-31$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001999480-26-000002.Report this figure7.3Current liabilities, Q1 FY2025, at 2025-03-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure8.1Current liabilities, Q2 FY2025, at 2025-06-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure9.0Current liabilities, Q3 FY2025, at 2025-09-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure11.3Current liabilities, FY2025, at 2025-12-31$11.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure13.1Current liabilities, Q1 FY2026, at 2026-03-31$13.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure16.7Current liabilities, Q2 FY2026, at 2026-06-30$16.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Total liabilities$mnot reported16.8Total liabilities, period not labelled, at 2023-12-31$16.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001999480-25-000025.Report this figure16.8Total liabilities, Q1 FY2024, at 2024-03-31$16.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure17.6Total liabilities, Q2 FY2024, at 2024-06-30$17.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001999480-24-000035.Report this figure26.6Total liabilities, Q3 FY2024, at 2024-09-30$26.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure26.1Total liabilities, FY2024, at 2024-12-31$26.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001999480-26-000002.Report this figure32.8Total liabilities, Q1 FY2025, at 2025-03-31$32.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure34.5Total liabilities, Q2 FY2025, at 2025-06-30$34.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure35.4Total liabilities, Q3 FY2025, at 2025-09-30$35.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure33.5Total liabilities, FY2025, at 2025-12-31$33.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure32.9Total liabilities, Q1 FY2026, at 2026-03-31$32.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure34.8Total liabilities, Q2 FY2026, at 2026-06-30$34.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Long-term debt$mnot reported9.9Long-term debt, period not labelled, at 2023-12-31$9.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-20, accession 0001999480-25-000025.Report this figure8.8Long-term debt, Q1 FY2024, at 2024-03-31$8.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure7.7Long-term debt, Q2 FY2024, at 2024-06-30$7.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-13, accession 0001999480-24-000035.Report this figure6.6Long-term debt, Q3 FY2024, at 2024-09-30$6.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure10.3Long-term debt, FY2024, at 2024-12-31$10.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-16, accession 0001999480-26-000002.Report this figure19.9Long-term debt, Q1 FY2025, at 2025-03-31$19.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure20.1Long-term debt, Q2 FY2025, at 2025-06-30$20.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure20.3Long-term debt, Q3 FY2025, at 2025-09-30$20.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure16.2Long-term debt, FY2025, at 2025-12-31$16.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure13.9Long-term debt, Q1 FY2026, at 2026-03-31$13.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure12.4Long-term debt, Q2 FY2026, at 2026-06-30$12.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Current portion of debt$mnot reported0.0Current portion of debt, period not labelled, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure1.1Current portion of debt, Q1 FY2024, at 2024-03-31$1.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure2.3Current portion of debt, Q2 FY2024, at 2024-06-30$2.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-13, accession 0001999480-24-000035.Report this figure3.5Current portion of debt, Q3 FY2024, at 2024-09-30$3.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-16, accession 0001999480-26-000002.Report this figurenot reportednot reportednot reported0.6Current portion of debt, FY2025, at 2025-12-31$585.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure2.1Current portion of debt, Q1 FY2026, at 2026-03-31$2.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure3.8Current portion of debt, Q2 FY2026, at 2026-06-30$3.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure
Shareholders' equity$m(61.1)Shareholders' equity, period not labelled, at 2023-09-30−$61.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure(71.7)Shareholders' equity, period not labelled, at 2023-12-31−$71.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001999480-26-000002.Report this figure193Shareholders' equity, Q1 FY2024, at 2024-03-31$193.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure180Shareholders' equity, Q2 FY2024, at 2024-06-30$179.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure165Shareholders' equity, Q3 FY2024, at 2024-09-30$165.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure151Shareholders' equity, FY2024, at 2024-12-31$151.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure139Shareholders' equity, Q1 FY2025, at 2025-03-31$139.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure123Shareholders' equity, Q2 FY2025, at 2025-06-30$123.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure112Shareholders' equity, Q3 FY2025, at 2025-09-30$111.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure151Shareholders' equity, FY2025, at 2025-12-31$151.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure243Shareholders' equity, Q1 FY2026, at 2026-03-31$243.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure219Shareholders' equity, Q2 FY2026, at 2026-06-30$219.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure

Cash flow

Operating cash flow−$19.8m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Alto Neuroscience, Inc., cash flow, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(7.8)Operating cash flow, period not labelled, three months to 2023-09-30−$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001999480-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure(11.5)Operating cash flow, period not labelled, three months to 2023-12-31−$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001999480-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(11.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$11.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure(11.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001999480-25-000076. Derived: 6-month figure less the 3-month figure.Report this figure(11.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001999480-25-000090. Derived: 9-month figure less the 6-month figure.Report this figure(13.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure(16.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure(13.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001999480-26-000023. Derived: 6-month figure less the 3-month figure.Report this figure(9.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001999480-25-000090. Derived: 9-month figure less the 6-month figure.Report this figure(11.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure(27.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$27.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure(19.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$19.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001999480-26-000023. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, three months to 2023-09-30$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001999480-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, period not labelled, three months to 2023-12-31$352.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0001999480-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$224.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$340.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001999480-25-000076. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001999480-25-000090. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$506.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001999480-26-000023. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001999480-25-000090. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001999480-26-000002. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$556.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001999480-26-000023. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)42.81m, Q2 FY2026
Alto Neuroscience, Inc., shares, quarterly
Line itemUnitperiod not labelled2023-03-31period not labelled2023-06-30period not labelled2023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares3.7Diluted shares (weighted), period not labelled, three months to 2023-03-313,691,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001999480-24-000022.Report this figure3.7Diluted shares (weighted), period not labelled, three months to 2023-06-303,716,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001999480-24-000035.Report this figure3.7Diluted shares (weighted), period not labelled, three months to 2023-09-303,742,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001999480-24-000042.Report this figure17.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3117,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001999480-25-000037.Report this figure26.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3026,913,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001999480-25-000076.Report this figure27.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3026,959,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure27.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3127,049,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure27.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3027,072,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure27.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3027,104,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001999480-25-000090.Report this figure32.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3132,893,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001999480-26-000012.Report this figure42.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3042,813,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure

Shares outstanding: 39.24mShares outstanding, period not labelled, at 2026-08-0739,242,104 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001999480-26-000023.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.